199 related articles for article (PubMed ID: 23924646)
1. Adipose-derived stem cells inhibit the contractile myofibroblast in Dupuytren's disease.
Verhoekx JSN; Mudera V; Walbeehm ET; Hovius SER
Plast Reconstr Surg; 2013 Nov; 132(5):1139-1148. PubMed ID: 23924646
[TBL] [Abstract][Full Text] [Related]
2. Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target.
Verjee LS; Verhoekx JS; Chan JK; Krausgruber T; Nicolaidou V; Izadi D; Davidson D; Feldmann M; Midwood KS; Nanchahal J
Proc Natl Acad Sci U S A; 2013 Mar; 110(10):E928-37. PubMed ID: 23431165
[TBL] [Abstract][Full Text] [Related]
3. Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells.
Verjee LS; Midwood K; Davidson D; Eastwood M; Nanchahal J
J Cell Physiol; 2010 Sep; 224(3):681-90. PubMed ID: 20432463
[TBL] [Abstract][Full Text] [Related]
4. Cellular structure and biology of Dupuytren's disease.
Tomasek JJ; Vaughan MB; Haaksma CJ
Hand Clin; 1999 Feb; 15(1):21-34. PubMed ID: 10050239
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandins influence myofibroblast contractility in Dupuytren's disease.
Badalamente MA; Hurst LC; Sampson SP
J Hand Surg Am; 1988 Nov; 13(6):867-71. PubMed ID: 3225412
[TBL] [Abstract][Full Text] [Related]
6. Dupuytren's disease susceptibility gene, EPDR1, is involved in myofibroblast contractility.
Staats KA; Wu T; Gan BS; O'Gorman DB; Ophoff RA
J Dermatol Sci; 2016 Aug; 83(2):131-7. PubMed ID: 27245865
[TBL] [Abstract][Full Text] [Related]
7. Feedback inhibition of high TGF-beta1 concentrations on myofibroblast induction and contraction by Dupuytren's fibroblasts.
Wong M; Mudera V
J Hand Surg Br; 2006 Oct; 31(5):473-83. PubMed ID: 16875762
[TBL] [Abstract][Full Text] [Related]
8. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation.
Jemec B; Linge C; Grobbelaar AO; Smith PJ; Sanders R; McGrouther DA
Chir Main; 2000 Feb; 19(1):15-22. PubMed ID: 10777424
[TBL] [Abstract][Full Text] [Related]
9. The myofibroblast in Dupuytren's contracture.
Rudolph R; Vande Berg J
Hand Clin; 1991 Nov; 7(4):683-92; discussion 693-4. PubMed ID: 1769990
[TBL] [Abstract][Full Text] [Related]
10. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
Tomasek J; Rayan GM
J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
[TBL] [Abstract][Full Text] [Related]
11. Identification of mesenchymal stem cells in perinodular fat and skin in Dupuytren's disease: a potential source of myofibroblasts with implications for pathogenesis and therapy.
Iqbal SA; Manning C; Syed F; Kolluru V; Hayton M; Watson S; Bayat A
Stem Cells Dev; 2012 Mar; 21(4):609-22. PubMed ID: 21612554
[TBL] [Abstract][Full Text] [Related]
12. Generation of contractile force by cultured Dupuytren's disease and normal palmar fibroblasts.
Rayan GM; Tomasek JJ
Tissue Cell; 1994 Oct; 26(5):747-56. PubMed ID: 9437248
[TBL] [Abstract][Full Text] [Related]
13. Mechanical and migratory properties of normal, scar, and Dupuytren's fibroblasts.
Viji Babu PK; Rianna C; Belge G; Mirastschijski U; Radmacher M
J Mol Recognit; 2018 Sep; 31(9):e2719. PubMed ID: 29701269
[TBL] [Abstract][Full Text] [Related]
14. Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease.
Alfonso-Rodríguez CA; Garzón I; Garrido-Gómez J; Oliveira AC; Martín-Piedra MÁ; Scionti G; Carriel V; Hernández-Cortés P; Campos A; Alaminos M
PLoS One; 2014; 9(11):e112457. PubMed ID: 25379672
[TBL] [Abstract][Full Text] [Related]
15. Beta-catenin overexpression in Dupuytren's disease is unrelated to disease recurrence.
Degreef I; De Smet L; Sciot R; Cassiman JJ; Tejpar S
Clin Orthop Relat Res; 2009 Mar; 467(3):838-45. PubMed ID: 18958538
[TBL] [Abstract][Full Text] [Related]
16. Dupuytren's fibroblast contractility by sphingosine-1-phosphate is mediated through non-muscle myosin II.
Komatsu I; Bond J; Selim A; Tomasek JJ; Levin LS; Levinson H
J Hand Surg Am; 2010 Oct; 35(10):1580-8. PubMed ID: 20888494
[TBL] [Abstract][Full Text] [Related]
17. Isometric contraction of Dupuytren's myofibroblasts is inhibited by blocking intercellular junctions.
Verhoekx JSN; Verjee LS; Izadi D; Chan JKK; Nicolaidou V; Davidson D; Midwood KS; Nanchahal J
J Invest Dermatol; 2013 Dec; 133(12):2664-2671. PubMed ID: 23652794
[TBL] [Abstract][Full Text] [Related]
18. Dupuytren's disease: physiologic changes in nodule and cord fibroblasts through aging in vitro.
Moyer KE; Banducci DR; Graham WP; Ehrlich HP
Plast Reconstr Surg; 2002 Jul; 110(1):187-93; discussion 194-6. PubMed ID: 12087251
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel.
Bisson MA; Beckett KS; McGrouther DA; Grobbelaar AO; Mudera V
J Hand Surg Am; 2009; 34(6):1102-10. PubMed ID: 19505772
[TBL] [Abstract][Full Text] [Related]
20. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
